Finepoint Capital Lp Top Holdings and 13F Report (2023) About Finepoint Capital LpInvestment ActivityFinepoint Capital Lp has $1.38 billion in total holdings as of December 31, 2022.Finepoint Capital Lp owns shares of 26 different stocks, but just 4 companies or ETFs make up 80% of its holdings.Approximately 69.87% of the portfolio was purchased this quarter.About 0.02% of the portfolio was sold this quarter.This quarter, Finepoint Capital Lp has purchased 25 new stocks and bought additional shares in 8 stocks.Finepoint Capital Lp sold shares of 0 stocks and completely divested from 3 stocks this quarter.Largest Holdings QXO INC $406,089,816SPDR S&P 500 ETF Trust $318,436,800iShares Russell 2000 ETF $235,247,850Liberty Broadband $154,155,678Revolution Medicines $33,194,386 Largest New Holdings this Quarter QXO INC $406,089,816 HoldingSPDR S&P 500 ETF Trust $318,436,800 HoldingiShares Russell 2000 ETF $235,247,850 HoldingCALIDI BIOTHERAPEUTICS INC $14,249 Holding Largest Purchases this Quarter QXO INC 25,750,781 shares (about $406.09M)SPDR S&P 500 ETF Trust 555,000 shares (about $318.44M)iShares Russell 2000 ETF 1,065,000 shares (about $235.25M)Galapagos 15,000 shares (about $431.85K)SpringWorks Therapeutics 12,500 shares (about $400.50K) Sector Allocation Over TimeMap of 500 Largest Holdings ofFinepoint Capital Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorQXO INC$406,089,816$406,089,816 ▲New Holding25,750,78129.5%COM NEWSPYSPDR S&P 500 ETF Trust$318,436,800$318,436,800 ▲New Holding555,00023.1%FinanceIWMiShares Russell 2000 ETF$235,247,850$235,247,850 ▲New Holding1,065,00017.1%FinanceLBRDKLiberty Broadband$154,155,6780.0%1,994,51011.2%Consumer DiscretionaryRVMDRevolution Medicines$33,194,386$113,194 ▲0.3%731,9602.4%MedicalARGXargenx$29,504,330$216,832 ▲0.7%54,4282.1%MedicalASNDAscendis Pharma A/S$28,379,650$119,448 ▲0.4%190,0722.1%MedicalTVTXTravere Therapeutics$24,933,915$77,491 ▲0.3%1,782,2671.8%MedicalSWTXSpringWorks Therapeutics$20,853,298$400,500 ▲2.0%650,8521.5%MedicalMLTXMoonLake Immunotherapeutics$19,605,0610.0%388,8351.4%MedicalSRPTSarepta Therapeutics$16,677,186$87,423 ▲0.5%133,5351.2%MedicalGLPGGalapagos$16,057,968$431,850 ▲2.8%557,7621.2%MedicalARVNArvinas$14,146,9300.0%574,3781.0%MedicalACADACADIA Pharmaceuticals$13,924,8060.0%905,3841.0%MedicalCYTKCytokinetics$13,540,5070.0%256,4491.0%MedicalRLAYRelay Therapeutics$11,513,114$147,264 ▲1.3%1,626,1460.8%MedicalPRTAProthena$7,251,9700.0%433,4710.5%MedicalSLDBSolid Biosciences$6,699,9190.0%961,2510.5%MedicalEYPTEyePoint Pharmaceuticals$5,652,1580.0%707,4040.4%MedicalIVCPWSwiftmerge Acquisition$39,2000.0%490,0000.0%Financial ServicesCDAQWCompass Digital Acquisition$28,0540.0%459,9060.0%Financial ServicesMONEYHERO LIMITED$26,8500.0%895,0000.0%*W EXP 09/13/202GATEWMarblegate Acquisition$25,2840.0%735,0000.0%Financial ServicesYSBPWYS Biopharma$24,2060.0%489,9990.0%MedicalCALIDI BIOTHERAPEUTICS INC$14,249$14,249 ▲New Holding12,5000.0%COM NEWCALIDI BIOTHERAPEUTICS INC$8,5830.0%655,2000.0%*W EXP 03/14/202CHURCHILL CAPITAL CORP VII$0$191,800 ▼-100.0%00.0%*W EXP 02/29/202CONCORD ACQUISITION CORP II$0$44,917 ▼-100.0%00.0%*W EXP 99/99/999CALIDI BIOTHERAPEUTICS INC$0$25,000 ▼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
